Primary cells as feeder cells for coculture expansion of human hematopoietic stem cells from umbilical cord blood - A comparative study

Stem Cells and Development

Volumn 18, Issue 1, 2009, Pages 173-186

  Magin, A S ^a,c   Korfer N R ^a   Partenheimer, H ^a   Lange, C ^b   Zander, A ^b   Noll, T ^a  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; CD71 ANTIGEN; ENDOGLIN; INTERLEUKIN 2 RECEPTOR ALPHA; THY 1 ANTIGEN; BIOLOGICAL MARKER; CULTURE MEDIUM;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CD34 SELECTION; CELL; CELL EXPANSION; CELL ISOLATION; CELL TYPE; COCULTURE; COLONY FORMING CELL; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; T LYMPHOCYTE; UMBILICAL CORD BLOOD; UMBILICAL VEIN; WHARTON JELLY; ANIMAL; CELL CULTURE; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; FETUS BLOOD; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; PROCEDURES;

ANIMALS; ANTIGENS, CD34; BIOLOGICAL MARKERS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, SERUM-FREE; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTES;

EID: 60149090311     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0273     Document Type: Article

References (58)

1. Gluckman E and V Rocha. (2004). Cord blood transplantation in Europe: strategy of alternative donor transplant search. In: Cord Blood: Biology, Immunology, Banking, and Clinical Transplantation. Broxmeyer HE, ed. AABB Press, Bethesda, MD, pp 381-401.
2. Hofmeister CC, J Zhang, KL Knight, P Le and PJ Stiff. (2007). Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transpl 39:11-23.
3. Hough RE, JN Barker and JE Wagner. (2004). Innovation in umbilical cord blood transplantation. In: Cord Blood: Biology, Immunology, Banking, and Clinical Transplantation. Broxmeyer HA, ed. AABB Press, Bethesda, MD, pp 337-379.
4. Brunstein CG, JN Barker, DJ Weisdorf, TE DeFor, JS Miller, BR Blazar, PB McGlave and JE Wagner. (2007). Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 110:3064-3070.
5. Majumdar MK, MA Thiede, SE Haynesworth, SP Bruder and SL Gerson. (2000). Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 9: 841-848.
6. + cells. Exp Hematol 32:657-664.
7. - cells. Exp Hematol 28:841-852.
8. - cells and SCID-repopulating cells. Blood 105:576-583.
9. Jazwiec B, A Solanilla, C Grosset, FX Mahon, M Dupouy, V Pigeonnier-Lagarde, F Belloc, K Schweitzer, J Reiffers and J Ripoche. (1998). Endothelial cell support of hematopoiesis is differentially altered by IL-1 and glucocorticoids. Leukemia 12:1210-1220.
10. + cells on human endothelium transfected with adenovectors expressing thrombopoietin, c-kit ligand, and Flt-3 ligand. J Hematother Stem Cell Res 11:127-138.
11. + hematopoietic progenitor cells in coculture with autologous umbilical vein endothelial cells (HUVEC) is superior to cytokine-supplemented liquid culture. Bone Marrow Transpl 36:71-79.
12. +) PBPC through IL-6 secretion. Cytotherapy 8:335-342.
13. Mitchell KE, ML Weiss, BM Mitchell, P Martin, D Davis, L Morales, B Helwig, M Beerenstrauch, K Abou-Easa, T Hildreth and D Troyer. (2003). Matrix cells from Wharton's Jelly form neurons and glia. Stem Cells 21:50-60.
14. Bartholomew A, C Sturgeon, M Siatskas, K Ferrer, K McIntosh, S Patil, W Hardy, S Devine, D Ucker, R Deans, A Moseley and R Hoffman. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42-48.
15. Di Nicola M, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, P Matteucci, S Grisanti and AM Gianni. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843.
16. Sutherland HJ, DE Hogge, D Cook and CJ Eaves. (1993). Alternative mechanisms with and without steel factor support primitive human hematopoiesis. Blood 81:1465-1470.
17. Hogge DE, PM Lansdorp, D Reid, B Gerhard and CJ Eaves. (1996). Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor. Blood 88:3765-3773.
18. Koeffler HP and DW Golde. (1978). Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science 200:1153-1154.
19. Stute N, K Holtz, M Bubenheim, C Lange, F Blake and AR Zander. (2004). Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 32:1212-1225.
20. Jaffe EA, RL Nachman, CG Becker and CR Minick. (1973). Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745-2756.
21. Nguyen XD, H Eichler, A Dugrillon, C Piechaczek, M Braun and H Kluter. (2003). Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells. J Immunol Methods 275:57-68.
22. Ploemacher RE. (1997). Stem cells: characterization and measurement. Baillieres Clin Haematol 10:429-444.
23. Yamada T, Y Okamoto, H Kasamatsu, Y Horie, N Yamashita and K Matsumoto. (2000). Factors affecting the volume of umbilical cord blood collections. Acta Obstet Gynecol Scand 79:830-833.
24. Jelinek N, S Schmidt, U Hilbert, S Thoma, M Biselli and C Wandrey. (2002). Novel bioreactors for the ex vivo cultivation of hematopoietic cells. Eng Life Sci 2:15-18.
25. Müller AM, MI Hermanns, C Skrzynski, M Nesslinger, KM Muller and CJ Kirkpatrick. (2002). Expression of the endothelial markers PECAM-1, vWf, and CD34 in vivo and in vitro. Exp Mol Pathol 72:221-229.
26. Reyes M, T Lund, T Lenvik, D Aguiar, L Koodie and CM Verfaillie. (2001). Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98:2615-2625.
27. Devine SM. (2002). Mesenchymal stem cells: will they have a role in the clinic? J Cell Biochem Suppl 38:73-79.
28. Deans RJ and AB Moseley. (2000). Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28:875-884.
29. Schwachula A, D Riemann, A Kehlen and J Langner. (1994). Characterization of the immunophenotype and functional properties of fibroblast-like synoviocytes in comparison to skin fibroblasts and umbilical vein endothelial cells. Immunobiology 190:67-92.
30. Covas DT, JL Siufi, AR Silva and MD Orellana. (2003). Isolation and culture of umbilical vein mesenchymal stem cells. Braz J Med Biol Res 36:1179-1183.
31. Romanov YA, VA Svintsitskaya and VN Smirnov. (2003). Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21:105-110.
32. Mutin M, F Dignat-George and J Sampol. (1997). Immunologic phenotype of cultured endothelial cells: quantitative analysis of cell surface molecules. Tissue Antigens 50:449-458.
33. Lidington EA, DL Moyes, AM McCormack and ML Rose. (1999). A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions. Transpl Immunol 7:239-246.
34. Peister A, JA Mellad, BL Larson, BM Hall, LF Gibson and DJ Prockop. (2004). Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103:1662-1668.
35. Wang JM, S Kumar, A van Agthoven, P Kumar, D Pye and RD Hunter. (1995). Irradiation induces up-regulation of E9 protein (CD105) in human vascular endothelial cells. Int J Cancer 62:791-796.
36. Barry FP, RE Boynton, S Haynesworth, JM Murphy and J Zaia. (1999). The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun 265:134-139.
37. Sakaguchi Y, I Sekiya, K Yagishita, S Ichinose, K Shinomiya and T Muneta. (2004). Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood 104:2728-2735.
38. + peripheral blood progenitor cells and decrease their allostimulatory capacity. Exp Hematol 35:507-515.
39. Glennie S, I Soeiro, PJ Dyson, EW Lam and F Dazzi. (2005). Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105:2821-2827.
40. + T cells to endothelial cells in the absence of contaminating accessory cells. Transplantation 57:1628-1637.
41. Kunitomi A, T Hori, A Imura and T Uchiyama. (2000). Vascular endothelial cells provide T cells with costimulatory signals via the OX40/gp34 system. J Leukoc Biol 68:111-118.
42. + pre-CTL and induce less clonal expansion than matching B lymphoblastoid cells: development of a novel limiting dilution analysis method based on CFSE labeling of lymphocytes. J Immunol 166:3846-3854.
43. Weetman AP. (1999). The immunology of pregnancy. Thyroid 9:643-646.
44. Can A and S Karahuseyinoglu. (2007). Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 25:2886-2895.
45. Ball LM, ME Bernardo, H Roelofs, A Lankester, A Cometa, RM Egeler, F Locatelli and WE Fibbe. (2007). Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110:2764-2767.
46. Van Overstraeten-Schlogel N, Y Beguin and A Gothot. (2006). Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells. Eur J Haematol 76:488-493.
47. +) hematopoietic progenitor cells. J Cell Physiol 184:58-69.
48. -) early progenitors cultured over human MSCs as a feeder layer. Stem Cells 20:573-582.
49. Patel SD, ET Papoutsakis, JN Winter and WM Miller. (2000). The lactate issue revisited: novel feeding protocols to examine inhibition of cell proliferation and glucose metabolism in hematopoietic cell cultures. Biotechnol Prog 16:885-892.
50. Lombardi G, G Miglio, C Dianzani, R Mesturini, F Varsaldi, A Chiocchetti, U Dianzani and R Fantozzi. (2004). Glutamate modulation of human lymphocyte growth: in vitro studies. Biochem Biophys Res Commun 318:496-502.
51. da Silva CL, R Goncalves, KB Crapnell, JM Cabral, ED Zanjani and G Almeida-Porada. (2005). A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/ progenitor cells. Exp Hematol 33:828-835.
52. Yao CL, IM Chu, TB Hsieh and SM Hwang. (2004). A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical cord blood mononuclear cells. Exp Hematol 32:720-727.
53. Ivanovic Z, P Duchez, B Dazey, F Hermitte, I Lamrissi-Garcia, F Mazurier, V Praloran, J Reiffers, G Vezon and JM Boiron. (2006). A clinical-scale expansion of mobilized CD 34+ hematopoietic stem and progenitor cells by use of a new serum-free medium. Transfusion 46:126-131.
54. + progenitor cells in the absence of serum is suppressed by their progeny's production of serine proteinases. Stem Cells 24:299-306.
55. Kwok YK, MH Tang, HK Law, CS Ngai, YL Lau and ET Lau. (2007). Maternal plasma or human serum albumin in wash buffer enhances enrichment and ex vivo expansion of human umbilical cord blood CD34+ cells. Br J Haematol 137:468-474.
56. Meuleman N, T Tondreau, A Delforge, M Dejeneffe, M Massy, M Libertalis, D Bron and L Lagneaux. (2006). Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium. Eur J Haematol 76:309-316.
57. Korhonen M. (2007). Culture of human mesenchymal stem cells in serum-free conditions: no breakthroughs yet. Eur J Haematol 78:167; author reply 168.
58. Schallmoser K, C Bartmann, E Rohde, A Reinisch, K Kashofer, E Stadelmeyer, C Drexler, G Lanzer, W Linkesch and D Strunk. (2007). Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47:1436-1446.